中文速读
本研究针对甲状腺癌,通过体内外实验发现长链非编码RNA NR2F1-AS1通过海绵吸附miRNA-338-3p上调CCND1表达,促进甲状腺癌细胞增殖和迁移并抑制凋亡;体内实验使用Entranster-in vivo转染shRNA敲低NR2F1-AS1,显著抑制了裸鼠移植瘤的生长。
小鼠皮下肿瘤shRNAmiRNAlncRNAFTC-133B-CPAP
Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis
Feng Guo 1 , Qingfeng Fu 2 , Yang Wang 1 , Guoqing Sui 1
- 1 Department of Ultrasound, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
- 2 Jilin Provincial Key Laboratory of Surgical Translational Medicine, Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Abstract
Thyroid cancer (TC) is a prevalent endocrine malignant cancer whose pathogenic mechanism remains unclear. The aim of the study was to investigate the roles of long non-coding RNA (lncRNA) NR2F1-AS1/miRNA-338-3P/CCND1 axis in TC progression. Differentially expressed lncRNAs and mRNAs in TC tissues were screened out and visualized by R program. Relative expression of NR2F1-AS1, miRNA-338-3p and cyclin D1 (CCND1) was determined by quantitative real time polymerase chain reaction. In addition, Western blot analysis was adopted for evaluation of protein expression of CCND1. Targeted relationships between NR2F1-AS1 and miRNA-338-3p, as well as miRNA-338-3p and CCND1 were predicted using bioinformatics analysis and validated by dual-luciferase reporter gene assay. Besides, tumour xenograft assay was adopted for verification of the role of NR2F1-AS1 in TC in vivo. NR2F1-AS1 and CCND1 were overexpressed, whereas miRNA-338-3p was down-regulated in TC tissues and cell lines. Down-regulation of NR2F1-AS1 and CCND1 suppressed proliferation and migration of TC cells yet greatly enhanced cell apoptotic rate. Silence of NR2F1-AS1 significantly suppressed TC tumorigenesis in vivo. NR2F1-AS1 sponged miRNA-338-3p to up-regulate CCND1 expression to promote TC progression. Our study demonstrated that up-regulation of NR2F1-AS1 accelerated TC progression through regulating miRNA-338-3P/CCND1 axis.
Keywords: CCND1; NR2F1-AS1; miRNA-338-3P; thyroid cancer.
Cell Counting Kit-8 (CCK-8) 已有 26 篇已发表文献
同类研究
- Biomed Pharmacother. 2022 Oct;154:113529.doi: 10.1016/j.biopha.2022.113529. Epub 2022 Aug 26. (IF7.419) Praeruptorin B i…
- Front Oncol. 2022 Jul 14;12:882202.doi: 10.3389/fonc.2022.882202. eCollection 2022. (IF5.738) SETD3 Methyltransferase Re…
- J Cell Physiol.2019 Feb 14. doi: 10.1002/jcp.28314. MFGE8 protects against CCl 4 -induced liver injury by reducing apopt…
- J Cancer Res Clin Oncol . 2017 Nov;143(11):2171-2181. doi:10.1007/s00432-017-2470-y. α2,6-linked sialic acid serves as a…
- Mol Med Rep.2017 Oct;16(4):4593-4602. doi: 10.3892/mmr.2017.7201. CD147 blockade as a potential and novel treatment of g…
